01869 238000



Get up-to-date with our latest news and discover how other founders have flourished by reading our case studies.

Filter by articles in
October 27th 2022

Former HPIC customers DJS Antibodies has just been acquired by AbbVie for $255 million

Congratulations to DJS Antibodies, a biotechnology company dedicated to creating the next generation of antibody therapeutics, who started life at HPIC using shared lab bench space and have just been acquired by AbbVie for $255 million. HPIC are currently asking bio tech start-ups to apply for the opportunity to secure […]